2026 Approvals   Policy language can be found on ASHP's website.

March

• CEWD: Responsible Integration of Artificial Intelligence in Pharmacy Education and Training
• Discontinue CEWD: Fostering Leadership Development
• CPM: Safe Use of Controlled Substances Through Regulatory Reform
• CPM: Pharmacy Leadership Infusion Services
• Discontinue CPM: Name Change
• Discontinue CPhP: Ready-to-Use-Packaging for all Settings
• Discontinue CPhP: ASHP Statement on Reporting Medical Errors
• CPuP: Integrity of Pharmacist Provided Health Information
• Discontinue CPuP: Pharmacist Engagement in and Payment for Telehealth
• COT: Deregulation of Prescription Drugs
• COT: Drug Dosing in Conditions that Modify Pharmacokinetics and Pharmacodynamics
• COT: Direct-to-Consumer Clinical Genetic Tests

June

• CEWD: Optimizing Career Fulfillment in Pharmacy
• CEWD: Quality Of Pharmacy Education
  
• CPM: Advancing Technology Innovation and Vendor Accountability in Health-system Pharmacy
  
• CPM: Standard of Care Regulatory Model
  
• CPhP: Promoting Environmental Sustainability in Healthcare
  
• CPhP: Body Size Inclusivity
  
• CPhP: Pharmacy Workforce Leadership in Improving Vaccine Access
  
• CPhP: Pharmacy Workforce Right of Conscience and the Patient’s Right of Access to Therapy
  
• CPhP: Safe and Effective Compounding
  
• CPhP: Role of the Pharmacy Workforce to Combat Public Health Disinformation and Misinformation
  
• CPuP: FDA’s Public Health Role
  
• CPuP: Protecting the Pharmacy Workforce Against Unauthorized Synthetic Media
  
• COT: Tobacco and Nicotine Cessation and Control
  
• COT: Safe and Effective Use of Long-acting Injectable Antipsychotics
  
• COT: Dosing of Combination Antibiotics
  
• COT: Evidence-based Medicine